Fuller & Thaler Asset Management
SRGA

Fuller & Thaler Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Fuller & Thaler Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,660
Closed -$509K – 571
2021
Q4 		$509K Buy
23,660
+109
+0.5% +$2.92K ﹤0.01% 421
2021
Q3 		$770K Buy
+23,551
New +$862K 0.01% 401

Other funds holding SRGA

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management's SRGA Position: Q1 2022 in Review

Fuller & Thaler Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2022, closing a stake of 23,660 shares — an estimated $509K sold.

Fuller & Thaler Asset Management first reported a position in SRGA in Q3 2021 and held it in 2 quarters. The position peaked at $770K in Q3 2021. 77 funds tracked by Wall St. Rank hold SRGA as of Q1 2022.

  • Fuller & Thaler Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 23,660 Surgalign Holdings, Inc. Common Stock shares in Q1 2022, an estimated $509K.
  • Fuller & Thaler Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Fuller & Thaler Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $770K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2022.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2022, filed 13 May 2022.